Fibrocell
Karl Hyk is an accomplished clinical research professional with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as Associate Director of Clinical Research at Castle Creek Biosciences, Inc. since July 2019, Karl has held various positions including Sr. Clinical Trial Manager. Prior roles include Sr. Manager and Manager of Clinical Research at Cutanea Life Sciences, Inc., and Senior Clinical Research Associate at Insmed Incorporated. Karl's career also features a managerial role at Shriners Hospitals for Children and positions at PRA International, Galderma, and Kendle International Inc. Karl Hyk earned a Bachelor of Arts in Telecommunications from Penn State University in 2002.
Fibrocell
Fibrocell autologous cell and gene therapies target the underlying causes of diseases affecting the skin and connective tissue.